Sevion Therapeutics, Inc. 4
4 · Sevion Therapeutics, Inc. · Filed Feb 16, 2017
Insider Transaction Report
Form 4
BRACA JOHN N
Director
Transactions
- Award
Company Stock Option
2017-02-14$0.11/sh+167,045$18,375→ 167,045 totalExercise: $0.22From: 2017-02-14Exp: 2027-02-14→ Common Stock (167,045 underlying)
Footnotes (1)
- [F1]Such options were granted to Mr. Braca in lieu of cash compensation under the Company's independent director compensation plan and are immediately exercisable.